Clinical Trials Logo

Clinical Trial Summary

The aim of the study is to assess the effect of TheraCal PT pulpotomy versus MTA pulpotomy on the survival rate of cariously exposed vital primary molars.


Clinical Trial Description

for both interventions , 1. Informed consent from participating parents. 2. Baseline records photographs, percussion test, periapical radiograph and personal data collection. 3. Allocation (concealed by withdrawing a sealed opaque envelope containing eight times folded paper containing the type of dressing material that will be used then writing patient name and I.D. on it and will be opened after performing the access cavity). 4. Diagnostic chart with personal, medical and dental history will be filled. 5. Clinical examination will be performed to assess the clinical inclusion criteria. (Pulpal and periapical diagnosis is established after clinical examination). 6. Preoperative and Postoperative photographs will be taken. 7. The radiographic examination will be performed by taking periapical x-ray using (parallel technique) through machine to assess the inclusion criteria. The preoperative radiograph will serve as a reference for the follow-up radiographs. Standardization of the technique to avoid any distortion in the vertical dimension and to provide reproducible images using x-ray holding device. 8. Preoperative and postoperative radiograph will be taken by parallel technique using extension cone paralleling (XCP) film holder. 9. Administration of inferior alveolar nerve block (Septodont, Scandonest® 2% L Mepivacaine hydrochloride (HCl). 2% and Levonordefrin 1:20,000 Injection, U.S.P.) at the side of the affected tooth. 10. Application of rubber dam for isolation, then a standardized pulpotomy procedure will be performed using a large sterile round end bur in a high-speed handpiece with copious irrigation, a sharp spoon excavator will remove pulpal tissues to the orifice level. Hemostasis will be achieved by the application of a wet cotton pellet. Children will then be allocated into either one of the groups alternatively depending on the pulpotomy medicament used as follows: - Group I (Experimental group) TheraCal PT pulpotomy. - Group II (Control group) MTA pulpotomy. Group I (Experimental group) TheraCal PT: 1. After complete hemostasis, TheraCal PT (BISCO Dental Products, Schamberg illinois (IL), U.S.A.) will be applied according to the manufacturer's instructions and gently placed over the pulp stumps to a thickness of 2mm then the rest of the pulp chamber will be filled with glass ionomer cement. 2. Tooth will then be restored with stainless steel crown. Group II (Control group) MTA pulpotomy: 1. After complete hemostasis, MTA+ Curamed (ul. Kwiatkowskiego 1, 37-450 stylosa Wola, Polka) will be manipulated in the ratio of 3:1 (powder: liquid) to obtain a putty mix. This mix will be placed over the radicular pulp with the help of a suitable sterile amalgam carrier. Gentle condensation of the mix will be done in the pulp chamber with a moistened cotton pellet, followed by application of glass ionomer cement. 2. Tooth will then be restored with stainless steel crown. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04617600
Study type Interventional
Source Cairo University
Contact Reem Mohamed Gaber, B.Sc
Phone 01115578688
Email reem.gaber@dentistry.cu.edu.eg
Status Not yet recruiting
Phase N/A
Start date March 1, 2022
Completion date November 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT05167123 - Pulp Capping in Primary Molars Using TheraCal (LC) Phase 4
Recruiting NCT05144711 - Management of Deep Carious Lesions in Adults N/A
Completed NCT01224925 - RCT of Pulp Capping Over Carious Exposure in Adults N/A
Completed NCT03284697 - Direct Pulp Capping With MTA and Calcium Hydroxide. N/A
Completed NCT03286959 - Effect of Liners on Pulpal Outcome and Restoration Survival After Partial Caries Excavation N/A
Completed NCT04167943 - Conservative Pulp Therapy of Primary Molars Using TheraCAL Phase 3
Enrolling by invitation NCT02702505 - Success and Color Stability of MTA Pulpotomized Primary Molars: an RCT Phase 4
Active, not recruiting NCT05878249 - Role Of Wound Lavage in Direct Pulp Capping Of Permanent Teeth With Carious Exposure N/A
Not yet recruiting NCT06433297 - Comparative Evaluation of Indirect vs. Direct Pulp Capping in Deep Carious Mandibular Molars N/A
Terminated NCT01622153 - Electrical and Formocresol Pulpotomy in Primary Molars N/A
Active, not recruiting NCT03186690 - Similar Outcomes of Vital Pulp Therapy Using Mineral Trioxide Aggregate or Biodentineā„¢ N/A
Active, not recruiting NCT03071588 - Assessment of a New Protocol for Indirect Pulp Capping Procedures N/A
Active, not recruiting NCT02201641 - Efficacy of Calcium Silicate Pulp-capping; a Randomized Controlled Clinical Trial Phase 4
Recruiting NCT03741816 - Indirect Pulp Capping With Biodentine and TheraCal LC in Permanent Mature Molars N/A
Completed NCT04365270 - Antibacterial Effect and Clinical Performance of Chitosan Modified Glass Ionomer Phase 3
Completed NCT05145686 - The Role of Matrix Metalloproteinases on the Primary Teeth Pulpotomy Treatments Phase 1/Phase 2
Completed NCT00187837 - The CAP-1 Trial: Stepwise Excavation Versus One Completed Excavation in Deep Caries N/A
Active, not recruiting NCT04374214 - Effect of Simvastatin as Pulpotomy Agent in Cariously Exposed Permanent Molars N/A
Recruiting NCT06435065 - Direct Pulp Capping Agent on Human Pulp Tissue Phase 4
Not yet recruiting NCT04807244 - Treatment of Deep Carious Lesions With Selective Caries Removal, Partial or Full Pulpotomy N/A